ENCISION, INC.

ECIA ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $6.6M $6.6M $7.3M $7.7M $7.5M $7.7M $8.8M $8.8M
Cost of Revenue $3.0M $3.4M $3.3M $3.9M $3.6M $3.7M $4.1M $3.7M
Gross Profit $3.5M $3.1M $4.0M $3.8M $3.9M $4.0M $4.7M $5.0M
Gross Margin 53.6% 47.6% 54.9% 49.4% 51.8% 52.2% 53.1% 57.2%
Operating Expenses
Research & Development $593.2K $621.9K $816.1K $918.2K $569.5K $748.4K $779.5K $842.1K
SG&A Expense $1.4M $1.5M $1.5M $1.4M $1.4M $1.3M $1.3M $1.5M
Operating Income $-172.0K $-640.8K $-302.8K $-594.9K $-61.6K $-156.4K $-186.4K $395.8K
Operating Margin -2.6% -9.7% -4.1% -7.8% -0.8% -2.0% -2.1% 4.5%
Interest Expense $62.4K $19.5K $7.2K $87.1K
Pretax Income $-220.2K $-691.8K $-323.9K $-65.6K $584.7K $-198.3K $-236.1K $335.6K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $-220.2K $-691.8K $-323.9K $-65.6K $584.7K $-198.3K $-236.1K $335.6K
Net Margin -3.4% -10.5% -4.4% -0.9% 7.8% -2.6% -2.7% 3.8%
EPS (Basic) $-0.02 $-0.06 $-0.03 $-0.01 $0.05 $-0.02 $-0.02 $0.03
EPS (Diluted) $-0.02 $-0.06 $-0.03 $-0.01 $0.05 $-0.02 $-0.02 $0.03
Shares Outstanding (Basic) 11.9M 11.8M 11.8M 11.6M 11.6M 11.6M 10.9M 10.7M
Shares Outstanding (Diluted) 11.9M 11.8M 11.8M 11.6M 11.8M 11.6M 10.9M 10.7M
Dividends Per Share
← Newer Page 1 of 2 Older →